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INVITED EDITORIAL

Patient-centered Marketing Practices
for Pharma India
Vivek Hattangadi
Chief Mentor, The Enablers, Pharma Marketing Consultancy, Ahmedabad

The Indian Pharmaceuticals Market (IPM) is third largest in
terms of volume and thirteen largest in terms of value, as
per a pharmaceuticals sector analysis. It is highly fragmented,
with an estimated 25,000 companies. However, fewer than
300 are in the organized sector. Currently, chronic therapies
constitute 40 % of the market. In the coming decade
however, chronic therapies will dominate; by 2025, it may
constitute 65-70% of the IPM.
Although the IPM is growing at nearly 12 to 15 %, the
growth of the chronic therapy segment is over 25 %.This
growth could have been healthier, but for the myopic
marketing practices and the obsolete promotional tools.
Doctors are averse to this. They close their minds when
medical representatives start communicating. Yet Pharma
India is persisting with the traditional methods of marketing.
The New Marketing Myopia of Pharma India
Ted Levitt in 1960 coined the term ‘Marketing Myopia’. His
advice was to focus on customers. And this can come only
when Pharma India recognizes its true customer. Who is the
customer? Is it the doctor or the patient?
Historically, doctors have had a close relationship with the
pharmaceutical industry. This relation has come under close
scrutiny. Articles are written in medical journals, the lay
press, books are written and the social media is abuzz with
this subject. Kessler says that today’s marketing practices
have influenced the doctors but alienated the patients 1. It
is very true to India too. The marketing practices here have
inured to the disadvantage of the patients.
A paradigm shift in marketing practices is the need of the
hour. It is towards patient-centered marketing. The prime
importance to Pharma India should be a patient’s health and
welfare.
* For Correspondence:
E-mail: vivekhattangadi@yahoo.co.in

Patient Centered Marketing
Patient centricity means putting the needs and preferences
of the patients at the centre of marketing strategy. Here are
some of basics of patient-centric marketing.
Doctor-Patient Relationship
Medicine has changed a lot over the years, for the better
or the worse. Certainly the technology, medications, and
treatment options for diseases have improved over the years
and will continue to improve. Sadly, however, the quality of
the doctor-patient relationship has suffered a serious decline.
The main reason is that doctors no longer have enough time
to spend with an individual patient.
This is a good place for Pharma India to start. Patient
advocacy groups hardly exist in India. Pharma India can
initiate patient advocacy groups which can help doctors and
patients come closer and develop dependable relations. Ersoy
et al say that patient advocacy can help the patients obtain
information which will facilitate their ability to decide or
enable them to reach the sources of information2. Shah and
Garg add that such groups can be a liaison between patients
and doctors in order to improve or maintain high quality
of healthcare for the patients 3. These groups further can
develop creative support programs or provide educational
material for patients. Various services can be offered to
strengthen the bond between doctors and patients.
Patient adherence
Non-adherence is a major barrier in good patient care. Lack of
adherence to drug regimens is a serious health issue, especially
among the elderly. Adherence is the extent to which patients
follow the recommendations of the doctors on medication,
diet or lifestyle modifications. Non-adherence as per the
Frost and Sullivan Whitepaper can constitute many forms,
including not having a prescription filled, taking an incorrect
dose, taking medications at incorrect times, forgetting to take
doses, or stopping therapy before the recommended time4.
Medication non-adherence is not just a serious problem in
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healthcare; it carries an appreciable economic burden as well.
Although there is no Indian data on the revenue losses due
to non-adherence, as per Capgemini Consulting, globally the
revenue loss is estimated to be $564 billion5,6. Pharma India
must realize that investing on such patient-centric activities
can increase their sales revenues several fold.
Adherence programs fail because of the heavy dependence
on the busy doctors for implementation. Pharma India can
develop adherence programs for their drugs. It can change
the traditional marketing approach which is now embedded
in the socialization of doctors. At present, the notion of
crafting marketing strategy with the patient at the hub is
of considerable value. Patient-centric commercial strategy
holds considerable potential in generating revenue growth7.
Possibly, a collaboration among competitors, which is
unthinkable at this point of time, can decide the future of
industry growth via patient adherence programs.
Managing a chronic disease is complex and many factors
can impact successful treatment from lack of education
and patient apathy, to medication costs and environment.
Adherence becomes all the more important considering that
the share of chronic therapies is consistently increasing and
patients need indefinite treatment.
Communication with patients
Peters makes an important point: “Effective doctor-patient
communication is a central clinical function in building a therapeutic
doctor-patient relationship, which is the heart and art of medicine. This
is important in the delivery of high-quality health care”8.
The importance of this is not of recent origin but recognized
many years back. Hall et al said in 1981 that “Medicine is an art
whose magic and creative ability have long been recognized as residing in
the interpersonal aspects of patient-physician relationship”9.
Doctor’s communication and interpersonal skills will help
them get a better insight into the patient as an individual, not
just the disease. They will be able to elicit quality information
from the patient. This will not just facilitate precise diagnosis,
but will help in giving clear therapeutic instructions and
counseling. What’s more, excellence in communication will
establish caring relationships with patients.
In a country like India with diverse cultural and ethnic
background at times, through non-verbal communication,
the quality of interaction between doctors and patients can
certainly be better10.
2
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Pharma India can assist the healthcare givers in this field;
especially the nursing staff which needs to be educated in
communication with patients. Language is often a barrier
in effective interaction. Mandal and Basu in their article in
‘The Telegraph’ of 30 August 2014 reported that: “Doctors
and CEOs of some hospitals acknowledge that language is a problem
that sometimes nullifies the nursing skills these caregivers possess. For
patients, it can be a nightmare trying to convey something to a nurse
for whom Bengali or Hindi might as well be Greek. A nurse short on
language skills becomes a liability especially while handling a patient
in pain”11.
Communication does not mean just words. In my book on
“Total Communication©: The DNA for Effective Communication”,
I have pointed out that “Many doctors may not really understand
the incredible impact and importance of body language as this subject is
never taught in medical schools”12.
Are the medical professionals good listeners? One visit
to a medical college hospital will tell you how much time
a doctors has for the patients. In this milieu, listening to
patients is improbable. Empathy and Emotional Intelligence
are very important while treating patients. Empathy has
been the subject of thorough study in human sciences. Carl
Rogers says that empathy is one of the necessary conditions
of a functioning care giving relationship. The attitude of
comprehending their feelings and emotions and seeing things
from their point of view helps the medical professionals to
be more effective in caring for patients 13.
This ‘healing touch’ of empathy in communication can be
handled by the patient advocacy groups. Once again, Pharma
India could offer their services to doctors, especially the
upcoming ones.
Handling side effects
Medical science has not advanced to that extent that it has
been able to develop and produce drugs which are devoid of
side effects. Patients with chronic ailments have to live with
them. The emotional distress due to side effects is difficult
to handle. What are those side effects which are inevitable
and how to live with them should be an area of concern for
Pharma India. Patients can learn about the importance of
adherence to medication, side effects management through
videos produced by the manufacturing company. Pharma
India can address specific topics of concern to patients, with
the goal of advancing the knowledge of patient needs—for
example, managing side effects. This group can also address
the challenges faced by caregivers in caring for patients with
side effects. For instance, a patient who is undergoing chemo
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therapy, a caregiver at home, may not know if the signs of
distress are treatment or cancer related. Lack of information
about the side effects can result in confusion and distress for
the caregiver and the patient.
Geriatric attention
While the Indian ethos respects the senior citizens, advocacy
groups for such patients are non-existent. Many caregivers
may not be sure of what's going on with their elderly parent's
health. There is no one who can take the time to explain to
them. Falls are common and the leading cause of injuries
among people. Senior citizens have the right to information
about their health and the right to be treated with dignity and
respect. The doctor may genuinely be concerned about such
problems but may not have the time and wherewithal’s to
handle this. For Pharma India this is an opportunity to assist
and build relations with doctors.
CONCLUSION
From the retrograde marketing practices, can Pharma India
transit into patient-centric marketing? The established
commercial model needs more than just a revolution
–a paradigm shift is required. The traditional model of
pharmaceutical selling by demonstrating product efficacy
to prescribers is being challenged. Today, the medical
professionals have to face knowledgeable, engaged and
internet savvy patients who can confront them and challenge
their reputation. Pharma India must have at its heart the
development of genuine partnerships between doctors and
patients. It should nurture advocacy groups that prioritize
healthy patient outcomes. It is also essential that doctors
avoid putting their personal interest, or the interests of
pharmaceutical companies, before those of the patients.
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